A Common Denominator
As an educator, I always seek to condense and synthesize complex subjects into clearly understood principles. For example, there are many, many reasons why a person might faint. However, the "common denominator" in all wlho faint is a reduced blood flow to the brain.
In a real sense, Betsy and I are seeking to inform you, the lymphoma patient or caregiver, of another "common denominator".
There exist enormous complexities in lymphoma that relate to diagnosis, treatment options, cost and follow-up. Indeed, these are critically important. Yet, the most important factor---the "common denominator" is that the patient must come first. Not Medicare; not managed care plans; not reimbursement schedules for medical oncologists.
The principle of patient coming first should engender a second principle, namely, patient empowerment. The patient must control his destiny. The patient, not the physician, must be confident that all treatment options have been explored.
The patient must insist on the consultation with the physician who is experienced and has expertise in radioimmunotherapy.
Mort